As part of our integrated product development services, we provide commercial scale production for all of our product options from a global network of eight sites:
- Drug substances – intermediates, drug substances based on a full range of chemistry including HPAPI and ADC payloads
- Drug-product intermediates – micronized compounds, spray-dried compounds or dispersions, hot-melt extrudates
- Finished drug products – immediate and modified release tablets, encapsulated multiparticulates or powder-based formulations, liquid-filled hard capsules, softgels
This network facilitates seamless development, scale-up and commercialization of drug products. The option of working with one integrated partner can reduce timelines, complexity, risk and cost versus working with multiple partners.